How to set up agreements to conduct a clinical investigation?

por AKRN Scientific Consulting

Everyone involved in clinical research must follow Good Clinical Practice (GCP) as specified in ICH GCP and the international ISO standard 14155:2020, the EU MDR 2017/745, the EU IVDR 2017/746, the EU...

Leer más

OncoDNA provides strategic support in Radiomics' prospective clinical trial SALMON

por OncoDNA

Radiomics and OncoDNA are pleased to announce that they have entered into a strategic agreement, combining Radiomics’ next-generation AI-based technology to extract quantitative information embedded...

Leer más

Palobiofarma announces positive results in the Phase IIa clinical trial evaluating it´s first in class investigational treatment PBF-677 in patients with mild to moderate ulcerative colitis

por Palobiofarma

The Phase II trial studied the safety, tolerability, and preliminary efficacy of PBF-677 in patients with mild to moderate Ulcerative Colitis in flair condition on top of the standard of care Mesalazi...

Leer más

Palobiofarma announces positive results from the Phase II clinical trial evaluating the preliminary efficacy and safety of its adenosine A1 receptor antagonist PBF-680 in mild to moderate asthmatics patients

por Palobiofarma

The results confirm a clinically and statistically significant improvement in trough FEV1 of asthmatic patients taking 10mg of PBF-680 for 14 days compared to placebo.

Leer más

Pivotal is providing its specialized clinical research services for the conduct of a clinical trial in patients with COVID-19

por Pivotal

The clinical trial, which plans to include a total of up to 300 patients, has recently begun to include the first patients in Madrid and will incorporate up to 25 European center.

Leer más

Archivel's Ruti® vaccine begins clinical trial to increase the immunity of healthcare professionals exposed to Covid-19

por CataloniaBio

The General Directorate of Research and Innovation in Health of the Government of Ca​talonia will finance a clinical trial to study the protective effect of Ruti®, developed by A​rchivel Farma, o...

Leer más

Ability Pharmaceuticals Announces the Presentation of the First Results of ABTL0812 as First Line in Patients with Endometrial or Lung Cancer at 2019 ASCO Annual Meeting

por Ability Pharma

AbilityPharma (Ability Pharmaceuticals, SL) a biopharmaceutical company developing oncology drugs, announced today that the company will release the first results of the currently ongoing phase 1/2a c...

Leer más

TiGenix Cx601 positive long-term results to be presented at digestive disease week

por TIGENIX SAU

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop nove...

Leer más

Takeda and TiGenix report new data highlighting maintenance of long-term remission of complex perianal Fistulas in Crohn’s disease patients with Cx601

por TIGENIX SAU

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, ...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Identifican un gen potencialmente modifi...

by Universitat de Barcelona

Un artículo publicado en la revista Cells ha identificado un gen pote...

Diapositiva de Fotos